SHINE Technologies has completed the acquisition of the Lantheus SPECT portfolio and manufacturing facility while naming Michael Rossi as CEO of the new SHINE SPECT division...

Published by Nucleation Capital in Advanced Nuclear, Company Milestone, Fusion, Medical Isotopes, NEWS, Nuclear innovation, Nuclear R&D, Portfolio Venture, US competitiveness, Venture capital support for nuclear